Alterity Therapeutics Limited Share Price
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5100 AUD | -3.77% |
|
-7.27% | +27.50% |
| Market Cap | 7.68Cr 6.75Cr 6.3Cr 5.78Cr 11Cr 735.92Cr 11Cr 75Cr 29Cr 364.16Cr 29Cr 28Cr 1.26TCr | P/E 2026 * |
-0.3x | P/E 2027 * | -0.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.16Cr 2.78Cr 2.6Cr 2.38Cr 4.46Cr 303.09Cr 4.57Cr 31Cr 12Cr 149.98Cr 12Cr 12Cr 518.48Cr | EV / Sales 2026 * |
12.3x | EV / Sales 2027 * | 30x |
| Free-Float |
91.78% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | -3.77% | ||
| 1 week | -7.27% | ||
| Current month | -11.30% | ||
| 1 month | -8.93% | ||
| 3 months | +2.00% | ||
| 6 months | +27.50% | ||
| Current year | +27.50% |
| 1 week | 0.5 |  | 0.58 |
| 1 month | 0.5 | | 0.78 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.78 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.9 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
Abby Macnish
DFI | Director of Finance/CFO | - | 30/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/06/26 | Free | Chairman | 20,00,000 | 0.0184% | ||
| 15/06/26 | Free | Director | 10,00,000 | 0.0092% | ||
| 15/06/26 | Free | Director | 10,00,000 | 0.0092% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.77% | -7.27% | -36.25% | +45.71% | 8.04Cr | |
| +2.61% | +1.91% | +1.70% | +13.91% | 4.79TCr | |
| -1.60% | -1.29% | +385.56% | +603.70% | 3.91TCr | |
| -0.98% | +2.68% | +11.10% | +45.34% | 3.67TCr | |
| +1.90% | +22.79% | +25.18% | +9.47% | 4.05TCr | |
| +1.47% | +4.90% | +6.48% | +43.52% | 2.8TCr | |
| -0.94% | -1.23% | - | - | 1.68TCr | |
| +2.44% | +10.02% | +29.11% | +129.56% | 1.59TCr | |
| +0.18% | -1.46% | +4.92% | +10.14% | 1.36TCr | |
| -1.14% | +6.94% | -6.05% | -29.33% | 1.38TCr | |
| Average | -0.02% | +4.50% | +46.86% | +96.89% | 2.52TCr | |
| Weighted average by Cap. | +0.54% | +6.32% | +73.03% | +124.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.68L 22.57L 21.07L 19.33L 36.19L 25Cr 37.08L 2.5Cr 97.7L 12Cr 96.43L 94.34L 42Cr | 12L 10.55L 10L 9L 16.91L 11Cr 17.33L 1.17Cr 45.65L 5.69Cr 45.06L 44.09L 20Cr |
| Net income | -1.46Cr -1.29Cr -1.2Cr -1.1Cr -2.06Cr -140.26Cr -2.11Cr -14Cr -5.57Cr -69Cr -5.5Cr -5.38Cr -239.94Cr | -2.97Cr -2.61Cr -2.43Cr -2.23Cr -4.18Cr -284.1Cr -4.28Cr -29Cr -11Cr -140.58Cr -11Cr -11Cr -486Cr |
| Net Debt | -4.52Cr -3.97Cr -3.71Cr -3.4Cr -6.37Cr -432.83Cr -6.52Cr -44Cr -17Cr -214.18Cr -17Cr -17Cr -740.43Cr | -4.09Cr -3.59Cr -3.35Cr -3.08Cr -5.76Cr -391.58Cr -5.9Cr -40Cr -16Cr -193.77Cr -15Cr -15Cr -669.86Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | A$0.5100 | -3.77% | 1,64,413 |
| 28/26/28 | A$0.5300 | -6.19% | 68,232 |
| 27/26/27 | A$0.5650 | +0.89% | 14,025 |
| 24/26/24 | A$0.5600 | -2.61% | 2,58,611 |
| 23/26/23 | A$0.5750 | +1.77% | 61,936 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
